Epigenetic modulation of antitumor immunity for improved cancer immunotherapy

E Dai, Z Zhu, S Wahed, Z Qu, WJ Storkus, ZS Guo - Molecular cancer, 2021 - Springer
Epigenetic mechanisms play vital roles not only in cancer initiation and progression, but also
in the activation, differentiation and effector function (s) of immune cells. In this review, we …

The roles of histone deacetylases and their inhibitors in cancer therapy

G Li, Y Tian, WG Zhu - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Genetic mutations and abnormal gene regulation are key mechanisms underlying
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …

Advancing to the era of cancer immunotherapy

Y Wang, M Wang, HX Wu, RH Xu - Cancer Communications, 2021 - Wiley Online Library
Cancer greatly affects the quality of life of humans worldwide and the number of patients
suffering from it is continuously increasing. Over the last century, numerous treatments have …

[HTML][HTML] HDAC11: a rising star in epigenetics

SS Liu, F Wu, YM Jin, WQ Chang, TM Xu - Biomedicine & pharmacotherapy, 2020 - Elsevier
Epigenetic mechanisms, such as acetylation, methylation, and succinylation, play pivotal
roles in the regulation of multiple normal biological processes, including neuron regulation …

Histone deacetylase function in CD4+ T cells

W Ellmeier, C Seiser - Nature Reviews Immunology, 2018 - nature.com
The differentiation of T helper cell subsets and their acquisition of effector functions are
accompanied by changes in gene expression programmes, which in part are regulated and …

Histone deacetylase 11 is a fatty-acid deacylase

Z Kutil, Z Novakova, M Meleshin, J Mikesova… - ACS Chemical …, 2018 - ACS Publications
Histone deacetylase 11 (HDAC11) is a sole member of the class IV HDAC subfamily with
negligible intrinsic deacetylation activity. Here, we report in vitro profiling of HDAC11 …

[HTML][HTML] Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer

Y Lin, X Jing, Z Chen, X Pan, D Xu, X Yu, F Zhong… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: Studies have shown that the expression of histone deacetylases (HDACs) is
significantly related to the tumor microenvironment (TME) in gastric cancer. However, the …

HDAC11, an emerging therapeutic target for metabolic disorders

H Chen, C Xie, Q Chen, S Zhuang - Frontiers in Endocrinology, 2022 - frontiersin.org
Histone deacetylase 11 (HDAC11) is the only member of the class IV HDAC, and the latest
member identified. It is highly expressed in brain, heart, kidney and some other organs, and …

Immunoepigenetics combination therapies: an overview of the role of HDACs in cancer immunotherapy

D Banik, S Moufarrij, A Villagra - International journal of molecular …, 2019 - mdpi.com
Long-standing efforts to identify the multifaceted roles of histone deacetylase inhibitors
(HDACis) have positioned these agents as promising drug candidates in combatting cancer …

HDAC11 is a regulator of diverse immune functions

C Yanginlar, C Logie - Biochimica et Biophysica Acta (BBA)-Gene …, 2018 - Elsevier
Histone deacetylases deacetylate histone and non-histone protein targets. Aberrant HDAC
expression and function have been observed in several diseases, which make these …